Vaccines slip, Dupixent climbs for Sanofi as it readies multiple launches in 2023
Astellas taps new CEO
Biogen and Sage get FDA priority review of depression med zuranolone
Takeda following Takeda in exit from influential trade group PhRMA
*please scroll down for all the latest news*
